Swiftscale Biologics provides fast production services for biologics. At any scale from micrograms to grams, Swiftscale can produce proteins. Swiftscale can produce antibodies, enzymes, receptors, and other complex protein forms. Swiftscale was co-founded by Matthew DeLisa, a professor at Cornell, and Michael Jewett, a professor at Northwestern. In 2019, Swiftscale Biologics had a post valuation of $12.50M.
